Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 5, mitochondrial (NDUFB5), is an accessory subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase), the first and largest enzyme complex of the mitochondrial electron transport chain. Located in the inner mitochondrial membrane, NDUFB5 forms part of the transmembrane region of Complex I, which is crucial for transferring electrons from NADH to ubiquinone as part of cellular energy production. While essential for the assembly and structural integrity of Complex I, NDUFB5 itself is not catalytically active. Mutations or dysfunction in NDUFB5 and associated complex I subunits can contribute to mitochondrial and neurodegenerative diseases[1][2][3][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 5, mitochondrial (NDUFB5).